{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:11:03Z","timestamp":1780384263694,"version":"3.54.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jtct.2024.07.020","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T22:32:17Z","timestamp":1722119537000},"page":"1031.e1-1031.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluating Antibiotic De-escalation for Autologous Stem Cell Transplant Patients With Febrile Neutropenia in a Real-World Clinical Setting"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2158-5260","authenticated-orcid":false,"given":"Marshall D.","family":"Winget","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7454-7824","authenticated-orcid":false,"given":"Katie","family":"Gatwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5291-5945","authenticated-orcid":false,"given":"Reena","family":"Jayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3222-4079","authenticated-orcid":false,"given":"Eden","family":"Biltibo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Jallouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Jerkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagirathbhai","family":"Dholaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5182-3870","authenticated-orcid":false,"given":"Tae Kon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3304-9965","authenticated-orcid":false,"given":"Bipin","family":"Savani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0484-5903","authenticated-orcid":false,"given":"Adetola","family":"Kassim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"McNeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Orton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jtct.2024.07.020_bib0001","doi-asserted-by":"crossref","first-page":"e13225","DOI":"10.1111\/tid.13225","article-title":"Incidence of febrile neutropenia in autologous hematopoietic stem cell transplant (HSCT) recipients on levofloxacin prophylaxis","volume":"22","author":"Signorelli","year":"2020","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.jtct.2024.07.020_bib0002","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.bmt.1702503","article-title":"Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies","volume":"26","author":"\u00c7elebi","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2024.07.020_bib0003","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1200\/JOP.18.00269","article-title":"Optimal management of neutropenic fever in patients with cancer","volume":"15","author":"Zimmer","year":"2019","journal-title":"JOP"},{"key":"10.1016\/j.jtct.2024.07.020_bib0004","unstructured":"National Comprehensive Cancer Network. Prevention and treatment of cancer-related infections, (Version 1.2024).https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/infections.pdf. Accessed March 15, 2024."},{"issue":"4","key":"10.1016\/j.jtct.2024.07.020_bib0005","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jtct.2024.07.020_bib0006","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2024.07.020_bib0007","doi-asserted-by":"crossref","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","article-title":"Management of febrile neutropenia: ESMO clinical practice guidelines","volume":"27","author":"Klastersky","year":"2016","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.jtct.2024.07.020_bib0008","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.bbmt.2019.06.001","article-title":"Alteration of the intestinal microbiota by broad-spectrum antibiotic use correlates with the occurrence of intestinal graft-versus-host disease","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2024.07.020_bib0009","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1097\/TXD.0000000000000662","article-title":"Risk for Clostridium difficile infection after allogeneic hematopoietic cell transplant remains elevated in the post engraftment period","volume":"3","author":"Dubberke","year":"2017","journal-title":"Transplant Direct"},{"issue":"12","key":"10.1016\/j.jtct.2024.07.020_bib0010","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2352-3026(17)30211-9","article-title":"Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial","volume":"4","author":"Aguilar-Guisado","year":"2017","journal-title":"Lancet Haematol"},{"issue":"7","key":"10.1016\/j.jtct.2024.07.020_bib0011","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/23744235.2018.1438649","article-title":"Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study","volume":"50","author":"Le Clech","year":"2018","journal-title":"Infect Dis"},{"issue":"11","key":"10.1016\/j.jtct.2024.07.020_bib0012","doi-asserted-by":"crossref","first-page":"708.e1","DOI":"10.1016\/j.jtct.2023.08.013","article-title":"Early antibiotic de-escalation and discontinuation in patients with febrile neutropenia after cellular therapy: a single-center prospective unblinded randomized trial","volume":"29","author":"Ram","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"8","key":"10.1016\/j.jtct.2024.07.020_bib0013","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s00277-020-04132-0","article-title":"De-escalation of empiric broad spectrum antibiotics in hematopoietic stem cell transplant recipients with febrile neutropenia","volume":"99","author":"Rearigh","year":"2020","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.jtct.2024.07.020_bib0014","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1177\/1078155219865303","article-title":"Antimicrobial de-escalation in adult hematopoietic cell transplantation recipients with febrile neutropenia of unknown origin","volume":"26","author":"Petteys","year":"2020","journal-title":"J Oncol Pharm Pract"},{"issue":"9","key":"10.1016\/j.jtct.2024.07.020_bib0015","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1093\/jac\/dkac190","article-title":"Safety and risk of febrile recurrence after early antibiotic discontinuation in high-risk neutropenic patients with hematological malignancies: a multicenter observational study","volume":"77","author":"Paret","year":"2022","journal-title":"J Antimicrob Chemother"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724005505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724005505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T03:15:45Z","timestamp":1730949345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636724005505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2666636724005505"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2024.07.020","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating Antibiotic De-escalation for Autologous Stem Cell Transplant Patients With Febrile Neutropenia in a Real-World Clinical Setting","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2024.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}